Pharmacogenomics Focus Translational Software specializes in actionable pharmacogenomics (PGx) guidance and carrier screening, presenting an opportunity to upsell full PGx program implementation to hospitals and health systems expanding precision medicine initiatives.

Clinical Adoption With over 20 thousand clinicians served and more than one million support recommendations since 2013, there is demonstrated demand and a ready-made reference base to accelerate new client onboarding and pilot programs.

Platform Agnostic Delivering information in platform agnostic formats suggests a value proposition for health systems using diverse EHRs and care platforms, enabling seamless integration and cross-system adoption across large networks.

Strategic Partnerships Recent partnerships with MedImpact, RxGenomix, Exceltox, and PWN Health indicate a pattern of collaboration to expand access to pharmacogenomic testing and benefit programs, signaling a channel-focused sales approach.

Growth Path Revenue in the low-to-mid multi-million range and active expansion through launching PGx testing programs and clinical tools point to opportunities in enterprise deals with mid-market to health system customers seeking scalability and turnkey PGx solutions.